Kura Oncology (KURA) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Kura Oncology (KURA) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: November 7, 2024 (07:38)

Sector: Healthcare

The share price of Kura Oncology, Inc. (KURA) now

Latest session on the 6th of November for
Kura Oncology, Inc. is positive
Trading Volume: 1446634
Open: 18.04 /  High: 18.58 /  Low: 17.79
What analysts predict: $29.64
52-week High/Low: $24.17 / $8.17
50-Day Moving Average: $18.99 — resistance level today
200-Day Moving Average: $20.14 — resistance level today

Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2024, 2025, 2026. How much will one Kura Oncology share be worth in 2024 - 2026?

When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock? We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.


Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

Long-term forecasts by years.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Trending Themes in the Healthcare Sector

Kura Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 09 18.16 18.04 18.30 1.43
Nov 10 18.34 18.19 18.42 1.25
Nov 11 18.35 18.27 18.46 1.06
Nov 12 18.53 18.26 18.65 2.13
Nov 13 18.41 18.22 18.59 2.06
Nov 14 18.58 18.40 18.75 1.88
Nov 15 18.42 18.16 18.56 2.21
Nov 16 18.40 18.23 18.66 2.36
Nov 17 18.36 18.16 18.51 1.92
Nov 18 18.23 18.03 18.38 1.94
Nov 19 17.87 17.65 18.12 2.67
Nov 20 17.98 17.88 18.12 1.33
Nov 21 17.83 17.66 17.92 1.43
Nov 22 17.73 17.52 17.95 2.45
Nov 23 17.65 17.44 17.76 1.80
Nov 24 17.70 17.59 17.86 1.49
Nov 25 17.76 17.64 18.02 2.17
Nov 26 17.62 17.53 17.89 2.05
Nov 27 17.51 17.36 17.72 2.06
Nov 28 17.65 17.45 17.80 2.00
Nov 29 17.71 17.64 17.82 1.02
Nov 30 17.52 17.31 17.68 2.13
Dec 01 17.62 17.51 17.77 1.47
Dec 02 17.75 17.64 17.95 1.75
Dec 03 17.86 17.59 18.01 2.40
Dec 04 18.05 17.86 18.12 1.46
Dec 05 17.84 17.61 18.02 2.35
Dec 06 17.88 17.60 18.11 2.93
Dec 07 17.93 17.85 18.03 1.04
Dec 08 17.69 17.43 17.88 2.60

Kura Oncology Daily Price Targets


Kura Oncology Stock Forecast 11-09-2024.

Forecast target price for 11-09-2024: $18.16.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.409%.
Pessimistic target level: 18.04
Optimistic target level: 18.30

Kura Oncology Stock Forecast 11-10-2024.

Forecast target price for 11-10-2024: $18.34.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.234%.
Pessimistic target level: 18.19
Optimistic target level: 18.42

Kura Oncology Stock Forecast 11-11-2024.

Forecast target price for 11-11-2024: $18.35.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.053%.
Pessimistic target level: 18.27
Optimistic target level: 18.46

Kura Oncology Stock Forecast 11-12-2024.

Forecast target price for 11-12-2024: $18.53.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.087%.
Pessimistic target level: 18.26
Optimistic target level: 18.65

Kura Oncology Stock Forecast 11-13-2024.

Forecast target price for 11-13-2024: $18.41.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.020%.
Pessimistic target level: 18.22
Optimistic target level: 18.59

Kura Oncology Stock Forecast 11-14-2024.

Forecast target price for 11-14-2024: $18.58.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.844%.
Pessimistic target level: 18.40
Optimistic target level: 18.75

KURA (KURA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Dec. 18.84 17.29 20.70 16.45

Kura Oncology forecast for this year


Kura Oncology Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $18.8373. Pessimistic: $17.29. Optimistic: $20.70



Kura Oncology (KURA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 19.47 18.21 20.44 10.90
Feb 20.61 19.01 21.74 12.57
Mar 20.18 18.82 22.13 14.94
Apr 20.58 19.45 21.46 9.35
May 20.04 19.05 20.88 8.74
Jun 18.87 17.23 19.83 13.11
Jul 19.58 18.49 20.85 11.35
Aug 19.12 17.61 20.39 13.65
Sep 19.07 18.38 20.83 11.78
Oct 16.67 16.04 18.21 11.90
Nov 16.63 14.96 18.10 17.32
Dec 15.65 14.70 16.59 11.41

Kura Oncology (KURA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 14.86 14.28 15.61 8.54
Feb 16.52 15.23 17.66 13.74
Mar 18.39 16.64 19.18 13.21
Apr 19.92 19.12 21.21 9.89
May 20.10 18.72 21.96 14.76
Jun 19.55 18.05 21.46 15.87
Jul 19.12 17.35 20.21 14.14
Aug 18.80 16.84 20.46 17.68
Sep 18.14 16.53 19.95 17.13
Oct 16.84 15.42 17.65 12.65
Nov 17.17 15.87 18.93 16.15
Dec 16.23 14.99 17.16 12.67

Kura Oncology information and performance

Kura Oncology Address

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market Capitalization: 1 342 636 000 $

Market capitalization of the Kura Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KURA shares in the company outstanding by the market price of one share.

EBITDA: -199 224 992 $

EBITDA of Kura Oncology is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.479

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 76634000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.